XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
40.17
0.00 (0.00%)
Jul 13, 2026, 4:00 PM EDT - Market closed

XOMA Royalty Revenue

XOMA Royalty had revenue of $12.32M in the quarter ending March 31, 2026, a decrease of -22.59%. This brings the company's revenue in the last twelve months to $48.56M, up 13.16% year-over-year. In the year 2025, XOMA Royalty had annual revenue of $52.15M with 83.06% growth.

Revenue (ttm)
$48.56M
Revenue Growth
+13.16%
P/S Ratio
14.63
Revenue / Employee
$3,468,214
Employees
14
Market Cap
710.16M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202552.15M23.66M83.06%
Dec 31, 202428.49M23.73M498.72%
Dec 31, 20234.76M-1.27M-21.06%
Dec 31, 20226.03M-32.13M-84.21%
Dec 31, 202138.16M8.78M29.86%
Dec 31, 202029.39M11.02M59.96%
Dec 31, 201918.37M13.07M246.67%
Dec 31, 20185.30M-47.39M-89.94%
Dec 31, 201752.69M47.13M846.98%
Dec 31, 20165.56M-49.88M-89.97%
Dec 31, 201555.45M36.58M193.90%
Dec 31, 201418.87M-16.59M-46.78%
Dec 31, 201335.45M1.67M4.94%
Dec 31, 201233.78M-24.41M-41.95%
Dec 31, 201158.20M24.56M72.99%
Dec 31, 201033.64M-64.79M-65.82%
Dec 31, 200998.43M30.44M44.78%
Dec 31, 200867.99M-16.27M-19.31%
Dec 31, 200784.25M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sutro Biopharma99.61M
Arvinas89.40M
Assembly Biosciences71.10M
Crescent Biopharma11.88M
Ocugen4.47M
Shattuck Labs1.00M
ProKidney889.00K
Altimmune36.00K
Revenue Rankings